Should I buy or sell Bioceres Crop Solutions stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bioceres Crop Solutions in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" BIOX shares. View BIOX analyst ratings or view top-rated stocks .

What is Bioceres Crop Solutions' stock price target for 2024?

2 equities research analysts have issued 12 month target prices for Bioceres Crop Solutions' stock. Their BIOX share price targets range from $21.00 to $25.00. On average, they predict the company's stock price to reach $23.00 in the next year. This suggests a possible upside of 88.1% from the stock's current price. View analysts price targets for BIOX or view top-rated stocks among Wall Street analysts .

How have BIOX shares performed in 2024?

Bioceres Crop Solutions' stock was trading at $13.73 at the beginning of 2024. Since then, BIOX stock has decreased by 10.9% and is now trading at $12.23. View the best growth stocks for 2024 here .

Are investors shorting Bioceres Crop Solutions?

Bioceres Crop Solutions saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 342,600 shares, an increase of 17.7% from the March 15th total of 291,200 shares. Based on an average daily volume of 65,900 shares, the days-to-cover ratio is presently 5.2 days. Approximately 1.1% of the shares of the company are short sold. View Bioceres Crop Solutions' Short Interest .

When is Bioceres Crop Solutions' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our BIOX earnings forecast .

How were Bioceres Crop Solutions' earnings last quarter?

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) announced its earnings results on Thursday, February, 8th. The company reported $0.09 EPS for the quarter, topping analysts' consensus estimates of $0.07 by $0.02. The company had revenue of $140.30 million for the quarter, compared to analyst estimates of $108.97 million. Bioceres Crop Solutions had a net margin of 4.36% and a trailing twelve-month return on equity of 5.96%. During the same period last year, the firm posted ($0.14) EPS.

What ETFs hold Bioceres Crop Solutions' stock?

ETFs with the largest weight of Bioceres Crop Solutions (NASDAQ:BIOX) stock in their portfolio include Ballast Small/Mid Cap ETF (MGMT) and Global X MSCI Argentina ETF (ARGT) . Global X AgTech & Food Innovation ETF (KROP) .

What other stocks do shareholders of Bioceres Crop Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bioceres Crop Solutions investors own include Arcadia Biosciences (RKDA) , ChromaDex (CDXC) , Trevena (TRVN) , Advanced Micro Devices (AMD) , Amyris (AMRS) , Celldex Therapeutics (CLDX) , Chimerix (CMRX) , CTI BioPharma (CTIC) .

When did Bioceres Crop Solutions IPO?

Bioceres Crop Solutions (BIOX) raised $130 million in an initial public offering on Wednesday, February 7th 2018. The company issued 11,800,000 shares at $10.00-$12.00 per share. Jefferies, Piper Jaffray, Santander and SunTrust Robinson Humphrey served as the underwriters for the IPO and Mirabaud Securities was co-manager.

Who are Bioceres Crop Solutions' major shareholders?

Bioceres Crop Solutions' stock is owned by a number of institutional and retail investors. Top institutional investors include Fourth Sail Capital LP (2.59%).

How do I buy shares of Bioceres Crop Solutions?

Shares of BIOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Positive News SentimentPositive News

NASDAQ:BIOX

Bioceres Crop Solutions (BIOX) Stock Price, News & Analysis

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

Free BIOX Stock Alerts

$12.23

-0.22 (-1.77%)

(As of 04/18/2024 ET)

Compare

Today's Range: $12.09
▼
$12.50
50-Day Range: $12.23
▼
$13.86
52-Week Range: $9.76
▼
$14.20

Volume: 39,116 shs
Average Volume: 62,106 shs
Market Capitalization: $768.04 million

P/E Ratio: 38.22
Dividend Yield: N/A
Price Target: $23.00

Get Bioceres Crop Solutions alerts:

Bioceres Crop Solutions MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 88.1% Upside
$23.00 Price Target
Short Interest: Bearish
1.11% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.77
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 182.22%
From $0.45 to $1.27 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.86 out of 5 stars

Consumer Staples Sector

82nd out of 134 stocks

Agricultural Chemicals Industry

5th out of 6 stocks

3.5

Analyst's Opinion

Consensus Rating
Bioceres Crop Solutions has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Bioceres Crop Solutions has only been the subject of 1 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
1.11% of the float of Bioceres Crop Solutions has been sold short.
Short Interest Ratio / Days to Cover
Bioceres Crop Solutions has a short interest ratio ("days to cover") of 5.2.
Change versus previous month
Short interest in Bioceres Crop Solutions has recently increased by 17.65%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Bioceres Crop Solutions does not currently pay a dividend.
Dividend Growth
Bioceres Crop Solutions does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for BIOX.

3.2

News and Social Media Coverage

News Sentiment
Bioceres Crop Solutions has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Consumer Staples companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Bioceres Crop Solutions this week, compared to 0 articles on an average week.
Search Interest
2 people have searched for BIOX on MarketBeat in the last 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Bioceres Crop Solutions insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 2.31% of the stock of Bioceres Crop Solutions is held by insiders.
Percentage Held by Institutions
Only 17.68% of the stock of Bioceres Crop Solutions is held by institutions.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Bioceres Crop Solutions are expected to grow by 182.22% in the coming year, from $0.45 to $1.27 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Bioceres Crop Solutions is 38.22, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 144.15.
Price to Earnings Ratio vs. Sector
The P/E ratio of Bioceres Crop Solutions is 38.22, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 21.71.
Price to Book Value per Share Ratio
Bioceres Crop Solutions has a P/B Ratio of 2.33. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Bioceres Crop Solutions Stock (NASDAQ:BIOX)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Bolivia, Brazil, Colombia, Estonia, the United States, Paraguay, Russia, South Africa, France, Uruguay, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

BIOX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BIOX Stock News Headlines

April 16, 2024 | americanbankingnews.com

Short Interest in Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Increases By 17.7%

April 11, 2024 | markets.businessinsider.com

Pro Farm(TM) Group Inc and Ingenium(R) Group LLC Announce Zero Waste Achievement

April 19, 2024 | InvestorPlace (Ad)

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

March 23, 2024 | seekingalpha.com

Bioceres Needs To Add Clarity Around Borrowings

March 6, 2024 | businesswire.com

Bioceres Crop Solutions to Participate in the 36th Annual Roth Conference

March 6, 2024 | businesswire.com

Bioceres Crop Solutions to Participate in the 36th Annual Roth Conference

March 5, 2024 | investorplace.com

Financial Freedom Fighters: 3 Stocks to Liberate Your Portfolio

February 24, 2024 | morningstar.com

Bioceres Crop Solutions Corp

April 19, 2024 | InvestorPlace (Ad)

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

February 16, 2024 | wsj.com

Bioceres Crop Solutions Corp.

February 15, 2024 | investing.com

Bioceres Crop Solutions Corp (BIOX)

February 9, 2024 | finance.yahoo.com

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Q2 2024 Earnings Call Transcript

February 8, 2024 | finance.yahoo.com

Bioceres Crop Solutions Reports Fiscal Second Quarter 2024 Financial and Operational Results

February 7, 2024 | benzinga.com

Earnings Preview For Bioceres Crop Solutions

February 2, 2024 | finance.yahoo.com

Bioceres Crop Solutions Corp. (BIOX)

January 25, 2024 | finance.yahoo.com

Bioceres Crop Solutions to Host Fiscal Second Quarter 2024 Financial Results Conference Call on Thursday, February 8, 2024 at 4:30 p.m. Eastern Time

January 23, 2024 | finance.yahoo.com

Bioceres Crop Solutions Releases Scope 1 & 2 Greenhouse Gas Emissions Report

January 5, 2024 | benzinga.com

Bioceres Crop Solutions Stock (NASDAQ:BIOX) Dividends: History, Yield and Dates

December 27, 2023 | markets.businessinsider.com

Strong Buy for Bioceres Crop Solutions Amidst Robust Performance and Growth Prospects

December 8, 2023 | seekingalpha.com

Beware Of Impending Dilution At Bioceres

November 14, 2023 | seekingalpha.com

Bioceres Crop Solutions Corp. 2024 Q1 - Results - Earnings Call Presentation

November 12, 2023 | benzinga.com

Earnings Outlook For Bioceres Crop Solutions

November 1, 2023 | morningstar.com

Bioceres Crop Solutions Corp BIOX

November 1, 2023 | markets.businessinsider.com

Roth MKM Maintains Buy Rating for Bioceres Crop Solutions: Here's What You Need To Know

October 23, 2023 | finance.yahoo.com

Bioceres Crop Solutions Corp. (KYG1117K1141.SG)

October 13, 2023 | markets.businessinsider.com

Analysts Offer Insights on Industrial Goods Companies: Bioceres Crop Solutions (BIOX) and Bowman Consulting Group (BWMN)

October 13, 2023 | markets.businessinsider.com

Bioceres Crop Solutions’ Solid Long-Term Outlook Overshadows Current Challenges: An Analysis of the HB4 Program and Strategic Partnerships

See More Headlines

Receive BIOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioceres Crop Solutions and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/08/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/08/2024
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Consumer Staples
Industry: Agricultural chemicals
Sub-Industry: N/A
Current Symbol: NASDAQ:BIOX
CUSIP: N/A
CIK: 1769484
Web: biocerescrops.com
Phone: 543414861100
Fax: N/A
Employees: 447
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $23.00
High Stock Price Target: $25.00
Low Stock Price Target: $21.00
Potential Upside/Downside: +88.1%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.32
Trailing P/E Ratio: 38.22
Forward P/E Ratio: 27.18
P/E Growth: N/A
Net Income: $18.78 million
Net Margins: 4.36%
Pretax Margin: 5.55%
Return on Equity: 5.96%
Return on Assets: 2.40%

Debt

Debt-to-Equity Ratio: 0.33
Current Ratio: 1.24
Quick Ratio: 0.84

Sales & Book Value

Annual Sales: $419.80 million
Price / Sales: 1.83
Cash Flow: $0.57 per share
Price / Cash Flow: 21.63
Book Value: $5.26 per share
Price / Book: 2.33

Miscellaneous

Outstanding Shares: 62,800,000
Free Float: 61,346,000
Market Cap: $768.04 million
Optionable: Optionable
Beta: 0.58

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Jose A. Roque
General Counsel
Alex Garcia
Managing Director of Seeds
Dr. Federico Trucco Ph.D. (Age 47)
Executive Chairman & CEO
Comp: $131.16k
Mr. Enrique López Lecube (Age 42)
CFO & Executive Director
Comp: $129.89k
Mr. Jorge Wagner (Age 55)
Chief Operating Officer
Comp: $165.6k
Ms. Paula Savanti
Head of Investor Relations
Ms. Gloria Montaron Estrada (Age 53)
Executive Director
Mr. Ricardo Luis Yapur (Age 65)
Managing Director of Latam Unit & Chief Commercial Officer
Comp: $260k
Mr. Matti Tiainen (Age 34)
Managing Director of North America & Europe

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

BIOX Stock Analysis - Frequently Asked Questions

Should I buy or sell Bioceres Crop Solutions stock right now?: 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bioceres Crop Solutions in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" BIOX shares.
View BIOX analyst ratings or view top-rated stocks.
What is Bioceres Crop Solutions' stock price target for 2024?: 2 equities research analysts have issued 12 month target prices for Bioceres Crop Solutions' stock. Their BIOX share price targets range from $21.00 to $25.00. On average, they predict the company's stock price to reach $23.00 in the next year. This suggests a possible upside of 88.1% from the stock's current price.
View analysts price targets for BIOX or view top-rated stocks among Wall Street analysts.
How have BIOX shares performed in 2024?: Bioceres Crop Solutions' stock was trading at $13.73 at the beginning of 2024. Since then, BIOX stock has decreased by 10.9% and is now trading at $12.23.
View the best growth stocks for 2024 here.
Are investors shorting Bioceres Crop Solutions?: Bioceres Crop Solutions saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 342,600 shares, an increase of 17.7% from the March 15th total of 291,200 shares. Based on an average daily volume of 65,900 shares, the days-to-cover ratio is presently 5.2 days. Approximately 1.1% of the shares of the company are short sold.
View Bioceres Crop Solutions' Short Interest.
When is Bioceres Crop Solutions' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our BIOX earnings forecast.
How were Bioceres Crop Solutions' earnings last quarter?: Bioceres Crop Solutions Corp. (NASDAQ:BIOX) announced its earnings results on Thursday, February, 8th. The company reported $0.09 EPS for the quarter, topping analysts' consensus estimates of $0.07 by $0.02. The company had revenue of $140.30 million for the quarter, compared to analyst estimates of $108.97 million. Bioceres Crop Solutions had a net margin of 4.36% and a trailing twelve-month return on equity of 5.96%. During the same period last year, the firm posted ($0.14) EPS.

What ETFs hold Bioceres Crop Solutions' stock?: ETFs with the largest weight of Bioceres Crop Solutions (NASDAQ:BIOX) stock in their portfolio include Ballast Small/Mid Cap ETF (MGMT) and Global X MSCI Argentina ETF (ARGT).Global X AgTech & Food Innovation ETF (KROP).
What other stocks do shareholders of Bioceres Crop Solutions own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Bioceres Crop Solutions investors own include Arcadia Biosciences (RKDA), ChromaDex (CDXC), Trevena (TRVN), Advanced Micro Devices (AMD), Amyris (AMRS), Celldex Therapeutics (CLDX), Chimerix (CMRX), CTI BioPharma (CTIC).
When did Bioceres Crop Solutions IPO?: Bioceres Crop Solutions (BIOX) raised $130 million in an initial public offering on Wednesday, February 7th 2018. The company issued 11,800,000 shares at $10.00-$12.00 per share. Jefferies, Piper Jaffray, Santander and SunTrust Robinson Humphrey served as the underwriters for the IPO and Mirabaud Securities was co-manager.
Who are Bioceres Crop Solutions' major shareholders?: Bioceres Crop Solutions' stock is owned by a number of institutional and retail investors. Top institutional investors include Fourth Sail Capital LP (2.59%).
How do I buy shares of Bioceres Crop Solutions?: Shares of BIOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BIOX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Bioceres Crop Solutions (BIOX) Stock Price, News & Analysis

Bioceres Crop Solutions MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

Company Ownership

Earnings and Valuation

About Bioceres Crop Solutions Stock (NASDAQ:BIOX)

BIOX Stock Price History

BIOX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

BIOX Stock Analysis - Frequently Asked Questions

Overall MarketRank^™